(Q33723651)

28 July 2017

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer (English)

1 reference

28 July 2017

1 reference

A H M Reid

1

1 reference

28 July 2017

G Attard

2

1 reference

28 July 2017

L Ambroisine

3

1 reference

28 July 2017

G Fisher

4

1 reference

28 July 2017

G Kovacs

5

1 reference

28 July 2017

D Brewer

6

1 reference

28 July 2017

J Clark

7

1 reference

28 July 2017

P Flohr

8

1 reference

28 July 2017

S Edwards

9

1 reference

28 July 2017

D M Berney

10

1 reference

28 July 2017

C S Foster

11

1 reference

28 July 2017

A Fletcher

12

1 reference

28 July 2017

W L Gerald

13

1 reference

28 July 2017

H Møller

14

1 reference

28 July 2017

V E Reuter

15

1 reference

28 July 2017

P T Scardino

16

1 reference

28 July 2017

J Cuzick

17

1 reference

28 July 2017

J S de Bono

18

1 reference

28 July 2017

C S Cooper

19

1 reference

28 July 2017

Transatlantic Prostate Group

20

1 reference

28 July 2017

language of work or name

English

0 references

publication date

26 January 2010

1 reference

British Journal of Cancer

28 July 2017

1 reference

28 July 2017

102

1 reference

28 July 2017

678-684

1 reference

28 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605554

28 July 2017

0 references

cites work

Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

ETS gene fusions in prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Recurrent gene fusions in prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

The role of SPINK1 in ETS rearrangement-negative prostate cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Dissecting prostate carcinogenesis through ETS gene rearrangement studies: implications for anticancer drug development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Role of the TMPRSS2-ERG gene fusion in prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Estimates of the cancer incidence and mortality in Europe in 2006.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Long-term outcome among men with conservatively treated localised prostate cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Pten dose dictates cancer progression in the prostate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2837564

Influence of unrecognized molecular heterogeneity on randomized clinical trials

21 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

Observer variation in immunohistochemical analysis of protein expression, time for a change?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605554

ThePTEN gene in locally progressive prostate cancer is preferentially inactivated by bi-allelic gene deletion

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20104229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20104229

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6605554

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference